Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease
Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...
Serco Awarded $247M U.S. Army Holistic Health and Fitness (H2F) Contract
Serco, a provider of professional, technology, engineering, and management services, announced today that the Company has been awarded a new contract to support the optimization of Soldier readiness ...
Private Equity-Backed Medical Imaging Chain Hires CLO, Continuing C-Suite Makeover
"Health care organizations face an increasingly complicated business landscape. At the same time, the demand for their ...
Rocket’s new logo aims to tap into the ‘emotional’ side of buying a home
Rocket Mortgages, known as Quicken Loans before a 2021 rebrand, has been among the top mortgage lenders by overall business ...
Behind Rocket’s logo update and Super Bowl ambitions
CMO Jonathan Mildenhall explains how Rocket Companies is trying to own the homeownership journey through a brand refresh and ...
News Medical2d
U.S. dementia cases expected to surge with aging population
A new study shows that the risk of developing dementia anytime after age 55 among Americans is 42%, more than double the risk ...